The Wyss Institute’s Project Abbie is featured in HUBweek’s Hall of the Future, where HUBweek attendees will speak with the research team and learn about the Wyss’ approach to early detection and treatment of anaphylaxis.
Over 15 million Americans are at risk of anaphylaxis, a severe allergic reaction triggered by exposure to certain foods, materials, medications and insect bites. Every three minutes a food reaction sends someone to the emergency room. The Wyss Institute and the KeepSmilin4Abbie Foundation have partnered to advance research and development efforts in the early detection and treatment of anaphylaxis. The partnership aims to develop a deep understanding of the processes heralding an oncoming anaphylactic episode at the earliest stages in order to develop a wearable device for both rapid detection of anaphylaxis onset and automated injection of epinephrine.